FY2026 Earnings Forecast for Unity Biotechnology, Inc. Issued By Wedbush (NASDAQ:UBX)

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) – Equities research analysts at Wedbush cut their FY2026 earnings per share (EPS) estimates for Unity Biotechnology in a research report issued to clients and investors on Tuesday, April 25th. Wedbush analyst A. Argyrides now forecasts that the company will earn ($13.02) per share for the year, down […]

Related Keywords

Nathaniel Eames David ,Judith Campisi ,Jan Van Deursen ,Citigroup ,Acadian Asset Management ,Unity Biotechnology Company Profile ,Renaissance Technologies ,Nasdaq ,Unity Biotechnology Inc ,Virtu Financial ,Unity Biotechnology ,Get Rating ,Asset Management ,Street Corp ,Exoduspoint Capital Management ,Daohong Zhou ,South San Francisco ,Unity Biotechnology Daily ,Nasdaq Ubx ,Subx ,Medical ,Earnings Estimates ,Wedbush ,